Sterling Tech Announces Clinical Studies

Brookings, S.D.—Sterling Technology announced three studies underway on its colostrum-based products, Immunel and Tegricel. The first and second human clinical studies on Immunel will be performed at Natural Immune System Lab, Klamath Falls, Ore.; and Nutrasource Diagnostics, Canada, a University of Guelph associated contract research lab, in an open-label or double blind, placebo-controlled, crossover design, respectively. Both studies will investigate Immunel’s affect on immune health. The third study will investigate Tegricel’s affect on gut health. The open-label, placebo-controlled, crossover-designed study will also be performed at Natural Immune System Lab.